David W. Boyer
Chief Corp. Affairs Officer, Neurocrine Biosciences
Bought, 12 months
$0.0M
Sold, 12 months
$0.7M
Companies
1
Latest trade
Sep 14, 2026
Companies
Neurocrine BiosciencesChief Corp. Affairs Officer −$0.7MTrades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.
